Facebook
Twitter
LinkedIn
ForwardClinical Multidisciplinary Hematology & Oncology: The 19th Annual Review - 2025
This course offers Live (in-person) and Livestream (virtual) attendance options
Course Directors: Allison C. Rosenthal, D.O. and Christina S. Wu, M.B., B.Ch., M.D.
March 12 - 15, 2025 - The Westin Kierland Resort & Spa - Scottsdale, Arizona
This course offers attendees a comprehensive update in the diagnosis and management of key diseases in hematology and medical oncology. Presentations provide updates on new data and best practices for physicians and the healthcare team. The format for this activity is didactic presentations followed by Q&A sessions. In person and virtual attendance will be offered. Continuing medical education credits will be offered for physicians, APPs, pharmacists, and nurses.
| Registration - Live (in-person) | On or before December 12, 2024 | After December 12, 2024 |
| M.D. Ph.D. D.O. | $950 | $1025 |
| Allied Health, NP, PA, Residents, Fellows, Retired | $750 | $825 |
| Registration - Virtual (livestream) | ||
| M.D. Ph.D. D.O. | $950 | |
| Allied Health, NP, PA, Residents, Fellows, Retired | $750 | |
Target Audience
This course is designed for physicians, advanced practice providers, pharmacists, and nurses interested in the diagnosis and treatment of patients with hematologic and oncologic disorders. Hospitalists, family medicine providers, general internists, or other healthcare professionals may benefit from this program.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify optimal treatment selection for castrate-resistant prostate cancer patients.
- Identify targeted therapy for IDH 1 and 2 mutant grade 2 glioma patients.
- Review the first-line treatment options for metastatic colorectal cancer patients.
- Recognize different ways to manage stage III lung cancer.
- Identify the role of immunotherapy in the treatment of triple-negative breast cancer patients.
- Review the indications for bispecific T cell engagers (bispecific antibodies) in lymphoma.
- Review the potential toxicities and toxicity management for multiple myeloma patients receiving CART or bispecific antibodies.
- Describe the application of newly approved drugs for classical hematology.
- Identify treatment strategies for Richter’s transformation.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Clinical Multidisciplinary Hematology & Oncology | ||
March 12-15, 2025 | ||
All Presentations in Mountain Standard Time | ||
Program Schedule - Wednesday, March 12, 2025 |
| |
| Start | Topics | Faculty Name |
11:00 AM | Registration, Snacks/refreshments, and Exhibits |
|
12:00 PM | Welcome & Introductions |
|
| Session 1: CLL/Lymphoma | Moderator: Allison Rosenthal (MCA) | |
12:15 PM | Session 1 Pre-Test |
|
12:30 PM | Bispecific Therapy in DLBCL | Javier L. Munoz, M.D., M.B.A. |
12:55 PM | Management of Richter's Transformation | Paul J. Hampel, M.D. |
1:20 PM | Considerations in the Treatment of Elderly Patients with HL | Mazie Tsang, M.D. |
1:45 PM | Updates in T Cell Lymphoma | N. Nora Bennani, M.D |
2:10 PM | Q&A Panel Discussion | Session Faculty |
2:30 PM | Session 1 Post-Test |
|
2:45 PM | Refreshment Break and Exhibits |
|
| Session 2: GU Cancer | Moderator: Jason Brown, M.D., Ph.D. | |
3:05 PM | Session 2 Pre-Test |
|
3:15 PM | Treatments in Metastatic Bladder Cancer | Jason Brown, M.D., Ph.D. |
3:40 PM | Updates in Advanced Prostate Cancer Management | Mehmet Bilen, M.D. |
4:05 PM | Updates in Kidney Cancer Treatment | Yousef Zakharia, M.D. |
4:30 PM | Q&A Panel Discussion | Session Faculty |
4:50 PM | Session 2 Post-Test |
|
5:05 PM | Adjourn |
|
5:10 PM | Welcome Reception |
|
Program Schedule - Thursday, March 13, 2025 | ||
| Start | Topics | Faculty Name |
7:00 AM | Breakfast, Exhibits and Product Theater |
|
7:55 AM | Announcements |
|
| Session III: Melanoma, CNS Cancer, and Supportive Oncology | Moderator: Christina S. Wu, M.B., B.Ch., M.D. | |
8:00 AM | Session 3 Pre-Test |
|
8:15 AM | Targeted Therapies in Primary CNS Cancers | Shannon P. Fortin Ensign, M.D., Ph.D. |
8:40 AM | Is Neoadjuvant Therapy the Standard of Care in Melanoma? | Janice Mehnert, M.D. |
9:05 AM | Integrative Oncology: Supplements, Cannabis, and Beyond | John K. Camoriano, M.D. |
9:30 AM | Palliative Care: New Drugs and Procedures for Pain Management | Tyler K. Murphy, M.D. |
9:55 AM | Q&A Panel Discussion | Session Faculty |
10:15 AM | Session 3 Post-Test |
|
10:30 AM | AM Refreshment Break and Exhibits |
|
| Session IV: Myeloma/Leukemia and Venous Thromboembolism Management | Moderator: Allison Rosenthal, D.O. | |
10:50 AM | Session 4 Pre-Test |
|
11:05 AM | Bispecific T Cell Engagers (BITEs) for Relapsed or Refractory Myeloma | Saurabh Chhabra, M.D., M.S. |
11:30 AM | Management of Non Transplant Eligible AML | Mark R. Litzow, M.D. |
11:55 AM | Venous Thromboembolism Management Challenges | Ewa M. Wysokinska, M.D. |
12:20 PM | Q&A Panel Discussion | Session Faculty |
12:40 PM | Session 4 Post-Test |
|
1:00 PM | Lunch |
|
Session V: Advance Practice Provider Afternoon Session | Moderator: Carol P. Bryant, D.N.P., R.N., C.N.P., C.C.R.N. | |
1:55 PM | Session V Pre-Test |
|
2:10 PM | The Scoop on Bup(renorphine) for Cancer Pain Management | Hannah N. Farfour, APRN, D.N.P., AGNP-C |
2:35 PM | Bispecifics in Hem/Onc for 2025 | Deepti Behl, M.D. |
3:00 PM | PM Refreshment Break and Exhibits |
|
3:20 PM | AI in Hem/Onc | Irbaz B. Riaz, M.B.B.S., M.S. |
3:45 PM | Implementation and Evaluation of an AYA Program | Allison C. Rosenthal, D.O. |
4:10 PM | Q&A Panel Discussion | Session Faculty |
4:30 PM | Session V Post-Test |
|
4:45 PM | Adjourn |
|
Program Schedule - Friday, March 14, 2025 | ||
| Start | Topics | Faculty Name |
7:00 AM | Breakfast and Exhibits |
|
7:55 AM | Announcements |
|
| Session VI: GI Cancers | Moderator: Mitesh Borad | |
8:00 AM | Session VI Pre-Test |
|
8:10 AM | Key Note: Evolving Landscape of 1st Line Metastatic Colorectal Cancer | John Strickler, M.D. |
9:00 AM | Moving Systemic Therapy Earlier in the Management of HCC | Daniel H. Ahn, D.O. |
9:25 AM | Gastroesophageal Cancers: When to Give Immunotherapy? | Mohamad (Bassam) B. Sonbol, M.D. |
9:50 AM | Non-Chemotherapy Options for Biliary Cancer Patients | Tanios S. Bekaii-Saab, M.D. |
10:15 AM | Q&A Panel Discussion | Session Faculty |
10:35 AM | Session VI Post-Test |
|
10:45 AM | Refreshment Break and Exhibits |
|
| Session VII: Breast Cancer | Moderator: Lida A. Mina, M.D. (MCA) | |
11:05 AM | Session VII Pre-Test |
|
11:20 AM | Beyond CDK4/6 Inhibitors: Emerging Drug Targets for Endocrine Resistant Breast Cancer | Matthew P. Goetz, M.D. |
11:45 AM | Triple Negative Breast Cancer: Immunotherapy and Beyond | Lida A. Mina, M.D. |
12:10 PM | ADC’s in HER2 Positive Breast Cancer | Shakeela Bahadur, M.D. |
12:35 PM | Q&A Panel Discussion | Session Faculty |
12:55 PM | Session VII Post-Test |
|
1:05 PM | Session Adjourns |
|
1:15 PM | Lunch - Optional Non-CME Product Theater |
|
Advanced Practice Providers Session | Moderator: Farah Raheem, Pharm. D., R.Ph. | |
2:05 PM | Session 8 Pre-Test |
|
2:20 PM | Ocular Toxicities | Alexander R. Shusko JR, M.D. |
2:45 PM | GU Toxicities | Jennah J. Bauernfeind, Pharm.D., R.Ph., BCOP |
3:10 PM | PM Refreshment Break and Exhibits |
|
3:30 PM | Clinical Trials without Walls | Kim M. Barbel Johnson, D.O., M.P.H. |
3:55 PM | TILS-Advancing Forward in Hem Onc | Deepti Behl, M.D. |
4:20 PM | Q&A Panel Discussion | Session Faculty |
4:40 PM | Session 8 Post-Test |
|
4:55 PM | Adjourn |
|
Program Schedule - Saturday, March 15, 2025 | ||
| Start | Topics | Faculty Name |
7:00 AM | Breakfast, Exhibits and Optional Non-CME Product Theater |
|
7:55 AM | Announcements |
|
| Session IX: Head/Neck & Lung Cancer | Moderator: Ashish V. Chintakuntlawar, M.B.B.S., Ph.D. | |
8:00 AM | Session IX Pre-Test |
|
8:15 AM | Immunotherapy in Lung Cancer | Vinicius Ernani, M.D. |
8:40 AM | Targetable Therapy in Lung Cancer | Conor Steuer, M.D. |
9:05 AM | Multidisciplinary Care in Head/Neck Cancers | Ashish Chintakuntlawar, M.B.B.S., Ph.D. |
9:30 AM | Q&A Panel Discussion | Session Faculty |
9:50 AM | Session 9 Post-Test |
|
10:00 AM | Refreshment Break and Exhibits |
|
| Session X: Rare Lymphomas and Classical Hematology Updates | Moderator: Allison Rosenthal, D.O. | |
10:20 AM | Session 10 Pre-Test |
|
10:35 AM | Management of Waldenstrom's | Udit Yadav, M.B.B.S. |
11:00 AM | New Drugs in Classical Heme | Surbhi Shah, M.B.B.S. |
11:25 AM | Does Mantle Cell Lymphoma Still Need a Transplant? | Jonas Paludo, M.D. |
11:50 AM | New Strategies for Managing Bleeding Disorders | Leslie J. Padrnos, M.D. |
12:15 PM | Q&A Panel Discussion | Session Faculty |
12:35 PM | Session 10 Post-Test |
|
12:50 PM | Closing Comments and Adjourn |
|
Westin Kierland Resort & Spa
6902 East Greenway Parkway
Scottsdale, AZ 85254
Reservations: 1-888-627-9076
Online Reservations: https://book.passkey.com/go/hemonc2025
A block of rooms at a special group rate of $409 (USD), plus applicable local and state taxes, per night, is available for course participants and guests. A limited number of rooms are available two days prior to and two days after course dates.
For Mayo Clinic Hematology & Oncology, the mandatory resort fee is $25.00 (regularly $35) per room, per day, plus tax and includes the following services and amenities:
- Resort Wide premium wireless Internet access in guest rooms, public areas, and meeting space.
- Any local, long-distance (domestic), and 1-800 guest room calls.
- Access to Agave, The Arizona Spa facilities (guests must be at least 18 years or older), Run Concierge, and boot camp, yoga, and Wellness Walk classes.
- Complimentary two-hour bike rental per registered guest per day, based on availability.
- Tennis, Pickleball, and Basketball court privileges, including equipment rental.
Hotel Parking Fees:
- Overnight Self-parking: $20.00 per car, per day.
- Overnight Valet: $39.00 per car, per day.
Make your reservation online before the room block fills or the cut-off date, February 11, 2025. Room block is expected to sell out early. To avoid one night’s room/tax charge, reservations must be canceled at least seven (7) days prior to scheduled arrival.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Travel
AIRPORTS
Phoenix Sky Harbor International Airport PHX) – 8 miles or approximately 20 minutes to hotel
RECREATION / LEISURE ACTIVITIES
Click here for recreation or leisure activities.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 23.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 23.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 23.00 ACPE Knowledge contact hours. Participants should claim only the credit commensurate with the extent of their participation in the activity.
UAN Number: TBD
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 23.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
AOA
The American Osteopathic Association designates this program for a maximum of 23.00 AOA Category 2-A credits.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 23.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
| Day | Credits |
|---|---|
| Wednesday | 4.50 |
| Thursday | 7.00 |
| Friday | 7.25 |
| Saturday | 4.25 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 23.00 AAPA Category 1
- 23.00 ACPE
- 23.00 AMA PRA Category 1 Credit™
- 23.00 ANCC
- 23.00 AOA Category 2-A
- 23.00 Attendance
For information regarding exhibit opportunities, please reach out to Kristy Badder.
Please update your profile to let us know if you have dietary restrictions or access requirements.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Equity, Diversity and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which individual differences are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.